Pacify Medical Technologies: Financial Breakdown
Decoding financial health metrics of Pacify Medical Technologies
Total Revenue₹4.7 Lakh-91%Prev. FY
Total Expenses₹53.9 Lakh-36%Prev. FY
Profit After Tax₹-49.2 Lakh-37%Prev. FY
Total Assets₹16.3 Lakh-69%Prev. FY
FAQs on Financials of Pacify Medical Technologies
No. In FY25, Pacify Medical Technologies reported a net loss of ₹49.2 Lakh, so it was not profitable.
Pacify Medical Technologies's revenue declined 90.2% year-on-year, from ₹48.2 Lakh in FY24 to ₹4.7 Lakh in FY25.
Pacify Medical Technologies's estimated EBITDA for FY25 was ₹-48.7 Lakh, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY25, Pacify Medical Technologies posted revenue of ₹4.7 Lakh (down 90.2% YoY) and a net loss of ₹49.2 Lakh. Explore the full financials of Pacify Medical Technologies here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links